z-logo
open-access-imgOpen Access
Flucytosine therapeutic monitoring: 15 years experience from the UK
Author(s) -
Alessandro C. Pasqualotto,
Susan J. Howard,
Caroline B. Moore,
David W. Denning
Publication year - 2007
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkl550
Subject(s) - flucytosine , medicine , therapeutic drug monitoring , toxicity , intensive care medicine , pharmacology , antifungal , pharmacokinetics , dermatology , fluconazole
There is uniform consensus that flucytosine blood concentrations should be measured to avoid toxicity and ensure adequate efficacy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom